{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T19:33:45Z","timestamp":1783020825151,"version":"3.54.6"},"reference-count":88,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010877","name":"Shenzhen Science and Technology Innovation Committee","doi-asserted-by":"publisher","award":["JCYJ20250604144930041"],"award-info":[{"award-number":["JCYJ20250604144930041"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Shenzhen Science and Technology Innovation Committee","doi-asserted-by":"publisher","award":["JCYJ20240813142819026"],"award-info":[{"award-number":["JCYJ20240813142819026"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173666"],"award-info":[{"award-number":["82173666"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373193"],"award-info":[{"award-number":["82373193"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104060"],"award-info":[{"award-number":["82104060"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172649"],"award-info":[{"award-number":["82172649"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32070748"],"award-info":[{"award-number":["32070748"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017622","name":"Shenzhen Research and Development Program","doi-asserted-by":"publisher","award":["JCYJ20240805221507001"],"award-info":[{"award-number":["JCYJ20240805221507001"]}],"id":[{"id":"10.13039\/501100017622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017622","name":"Shenzhen Research and Development Program","doi-asserted-by":"publisher","award":["JCYJ 2022071718149001"],"award-info":[{"award-number":["JCYJ 2022071718149001"]}],"id":[{"id":"10.13039\/501100017622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010839","name":"Guangdong Institute of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010839","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515012317"],"award-info":[{"award-number":["2024A1515012317"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.apsb.2026.03.021","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T16:02:37Z","timestamp":1773676957000},"page":"3698-3728","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["(+)-Miliusol suppresses the Warburg effect and induces regulated cell death in triple-negative breast cancer through targeting EIF3D and remodeling cancer metabolism"],"prefix":"10.1016","volume":"16","author":[{"given":"Jin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiya","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7027-3340","authenticated-orcid":false,"given":"Xiaohan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5658-1791","authenticated-orcid":false,"given":"Ling","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingnan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongchao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9386-5967","authenticated-orcid":false,"given":"Lingyun","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhendan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3900-9486","authenticated-orcid":false,"given":"Bo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dahong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2026.03.021_bib1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","article-title":"Breast cancer","volume":"5","author":"Harbeck","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.apsb.2026.03.021_bib2","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","article-title":"Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease","volume":"13","author":"Bianchini","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.apsb.2026.03.021_bib3","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1158\/2159-8290.CD-18-1177","article-title":"Insights into molecular classifications of triple-negative breast cancer: improving patient selection for treatment","volume":"9","author":"Garrido-Castro","year":"2019","journal-title":"Cancer Discov"},{"key":"10.1016\/j.apsb.2026.03.021_bib4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41571-021-00565-2","article-title":"Treatment landscape of triple-negative breast cancer\u2014expanded options, evolving needs","volume":"19","author":"Bianchini","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.apsb.2026.03.021_bib5","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/annonc\/mdz133","article-title":"Targeting the PI3-kinase pathway in triple-negative breast cancer","volume":"30","author":"Pascual","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.apsb.2026.03.021_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2017.07.002","article-title":"Immunotherapy for triple-negative breast cancer: existing challenges and exciting prospects","volume":"32","author":"Jia","year":"2017","journal-title":"Drug Resist Updates"},{"key":"10.1016\/j.apsb.2026.03.021_bib7","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1056\/NEJMoa2119662","article-title":"Neoantigen T-cell receptor gene therapy in pancreatic cancer","volume":"386","author":"Leidner","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2026.03.021_bib8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cmet.2020.10.012","article-title":"Metabolic-pathway-based subtyping of triple-negative breast cancer reveals potential therapeutic targets","volume":"33","author":"Gong","year":"2021","journal-title":"Cell Metab"},{"key":"10.1016\/j.apsb.2026.03.021_bib9","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.apsb.2026.03.021_bib10","doi-asserted-by":"crossref","first-page":"3934","DOI":"10.1016\/j.apsb.2022.06.009","article-title":"Coordinated regulation of BACH1 and mitochondrial metabolism through tumor-targeted self-assembled nanoparticles for effective triple negative breast cancer combination therapy","volume":"12","author":"Yang","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2026.03.021_bib11","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.apsb.2021.05.012","article-title":"Fucoidan-functionalized activated platelet-hitchhiking micelles simultaneously track tumor cells and remodel the immunosuppressive microenvironment for efficient metastatic cancer treatment","volume":"12","author":"Guo","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2026.03.021_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.104658","article-title":"eIF3d: a driver of noncanonical cap-dependent translation of specific mRNAs and a trigger of biological\/pathological processes","volume":"299","author":"Ma","year":"2023","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2026.03.021_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112646","article-title":"Breast cancer cell mesenchymal transition and metastasis directed by DAP5\/eIF3d-mediated selective mRNA translation","volume":"42","author":"Alard","year":"2023","journal-title":"Cell Rep"},{"key":"10.1016\/j.apsb.2026.03.021_bib14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41419-021-04465-2","article-title":"Correction: EIF3D promotes gallbladder cancer development by stabilizing GRK2 kinase and activating PI3K\u2013AKT signaling pathway","volume":"13","author":"Zhang","year":"2021","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.apsb.2026.03.021_bib15","doi-asserted-by":"crossref","DOI":"10.1080\/01443615.2022.2130200","article-title":"EIF3D promoted cervical carcinoma through Warburg effect by interacting with GRP78","volume":"43","author":"Liu","year":"2023","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.apsb.2026.03.021_bib16","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1021\/np030195z","article-title":"Homogentisic acid derivatives from Miliusa balansae","volume":"67","author":"Huong","year":"2004","journal-title":"J Nat Prod"},{"key":"10.1016\/j.apsb.2026.03.021_bib17","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1021\/acs.jmedchem.8b01742","article-title":"In vitro and in vivo antitumor effects of plant-derived Miliusanes and their induction of cellular senescence","volume":"62","author":"Xu","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2026.03.021_bib18","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1021\/np300711e","article-title":"Glycolysis inhibitor screening identifies the bis-geranylacylphloroglucinol protonophore moronone from Moronobea coccinea","volume":"75","author":"Datta","year":"2012","journal-title":"J Nat Prod"},{"key":"10.1016\/j.apsb.2026.03.021_bib19","doi-asserted-by":"crossref","first-page":"14441","DOI":"10.1074\/jbc.M114.628826","article-title":"In silico modeling-based identification of glucose transporter 4 (GLUT4)-selective inhibitors for cancer therapy","volume":"290","author":"Mishra","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2026.03.021_bib20","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1021\/acschembio.8b00251","article-title":"Identification of compounds that decrease glioblastoma growth and glucose uptake in vitro","volume":"13","author":"Landis","year":"2018","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.apsb.2026.03.021_bib21","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1126\/science.aba4904","article-title":"Structure of a human 48S translational initiation complex","volume":"369","author":"Brito Querido","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.apsb.2026.03.021_bib22","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1146\/annurev-biochem-062917-012837","article-title":"Horizontal cell biology: monitoring global changes of protein interaction states with the proteome-wide cellular thermal shift assay (CETSA)","volume":"88","author":"Dai","year":"2019","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.apsb.2026.03.021_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2018.03.065","article-title":"Modulation of protein-interaction states through the cell cycle","volume":"173","author":"Dai","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2026.03.021_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104605","article-title":"Ferulin C triggers potent PAK1 and p21-mediated anti-tumor effects in breast cancer by inhibiting Tubulin polymerization in vitro and in vivo","volume":"152","author":"Yao","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.apsb.2026.03.021_bib25","doi-asserted-by":"crossref","first-page":"14192","DOI":"10.1021\/acs.jmedchem.0c02268","article-title":"Structure-guided design of a small-molecule activator of sirtuin-3 that modulates autophagy in triple negative breast cancer","volume":"64","author":"Zhang","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2026.03.021_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112648","article-title":"Design, synthesis and biological evaluation of novel HDAC inhibitors with improved pharmacokinetic profile in breast cancer","volume":"205","author":"Yao","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2026.03.021_bib27","doi-asserted-by":"crossref","first-page":"W357","DOI":"10.1093\/nar\/gkz382","article-title":"SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules","volume":"47","author":"Daina","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.apsb.2026.03.021_bib28","doi-asserted-by":"crossref","first-page":"W216","DOI":"10.1093\/nar\/gkac194","article-title":"DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update)","volume":"50","author":"Sherman","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.apsb.2026.03.021_bib29","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The Warburg effect: how does it benefit cancer cells?.","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.apsb.2026.03.021_bib30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41573-021-00339-6","article-title":"Targeting cancer metabolism in the era of precision oncology","volume":"21","author":"Stine","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2026.03.021_bib31","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cmet.2018.04.022","article-title":"Aerobic glycolysis controls myeloid-derived suppressor cells and tumor immunity via a specific CEBPB isoform in triple-negative breast cancer","volume":"28","author":"Li","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.apsb.2026.03.021_bib32","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1038\/s41467-020-17399-8","article-title":"Basement membrane damage by ROS- and JNK-mediated Mmp2 activation drives macrophage recruitment to overgrown tissue","volume":"11","author":"Diwanji","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.03.021_bib33","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41586-019-1526-3","article-title":"E-cadherin is required for metastasis in multiple models of breast cancer","volume":"573","author":"Padmanaban","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.03.021_bib34","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1039\/C4SC01963F","article-title":"The energy blocker inside the power house: Mitochondria targeted delivery of 3-bromopyruvate","volume":"6","author":"Marrache","year":"2015","journal-title":"Chem Sci"},{"key":"10.1016\/j.apsb.2026.03.021_bib35","doi-asserted-by":"crossref","first-page":"9741","DOI":"10.7150\/thno.46913","article-title":"P21-activated kinase 1: emerging biological functions and potential therapeutic targets in cancer","volume":"10","author":"Yao","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.apsb.2026.03.021_bib36","doi-asserted-by":"crossref","first-page":"787","DOI":"10.7150\/thno.78840","article-title":"ATPase family AAA domain-containing protein 2 (ATAD2): from an epigenetic modulator to cancer therapeutic target","volume":"13","author":"Fu","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.apsb.2026.03.021_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.stem.2017.08.018","article-title":"MYC controls human pluripotent stem cell fate decisions through regulation of metabolic flux","volume":"21","author":"Cliff","year":"2017","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.apsb.2026.03.021_bib38","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.1158\/1078-0432.CCR-15-0375","article-title":"Reversal of Warburg effect and reactivation of oxidative phosphorylation by differential inhibition of EGFR signaling pathways in non-small cell lung cancer","volume":"21","author":"De Rosa","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.apsb.2026.03.021_bib39","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1126\/science.abb2683","article-title":"Glycolysis fuels phosphoinositide 3-kinase signaling to bolster T cell immunity","volume":"371","author":"Xu","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.apsb.2026.03.021_bib40","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/24184","article-title":"The protein kinase Pak3 positively regulates Raf-1 activity through phosphorylation of serine 338","volume":"396","author":"King","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.03.021_bib41","doi-asserted-by":"crossref","first-page":"20093","DOI":"10.1074\/jbc.M112.426023","article-title":"p21-activated kinase 1 (PAK1) can promote ERK activation in a kinase-independent manner","volume":"288","author":"Wang","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2026.03.021_bib42","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1038\/sj.onc.1205302","article-title":"PAK1 primes MEK1 for phosphorylation by Raf-1 kinase during cross-cascade activation of the ERK pathway","volume":"21","author":"Coles","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.apsb.2026.03.021_bib43","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41580-019-0199-y","article-title":"mTOR at the nexus of nutrition, growth, ageing and disease","volume":"21","author":"Liu","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.apsb.2026.03.021_bib44","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ncb3231","article-title":"AMPK and PFKFB3 mediate glycolysis and survival in response to mitophagy during mitotic arrest","volume":"17","author":"Dom\u00e9nech","year":"2015","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.apsb.2026.03.021_bib45","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1158\/2159-8290.CD-18-1409","article-title":"Oncogenic KRAS induces NIX-mediated mitophagy to promote pancreatic cancer","volume":"9","author":"Humpton","year":"2019","journal-title":"Cancer Discov"},{"key":"10.1016\/j.apsb.2026.03.021_bib46","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1080\/15548627.2021.2016231","article-title":"Negative pressure wound therapy improves bone regeneration by promoting osteogenic differentiation via the AMPK\u2013ULK1\u2013autophagy axis","volume":"18","author":"Zhang","year":"2022","journal-title":"Autophagy"},{"key":"10.1016\/j.apsb.2026.03.021_bib47","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1158\/2159-8290.CD-19-0292","article-title":"Targeting autophagy in cancer: recent advances and future directions","volume":"9","author":"Amaravadi","year":"2019","journal-title":"Cancer Discov"},{"key":"10.1016\/j.apsb.2026.03.021_bib48","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nrc.2017.53","article-title":"Targeting autophagy in cancer","volume":"17","author":"Levy","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.apsb.2026.03.021_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107690","article-title":"Target identification and validation of natural products with label-free methodology: a critical review from 2005 to 2020","volume":"216","author":"Dai","year":"2020","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.apsb.2026.03.021_bib50","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.1039\/D3CS00100H","article-title":"Chemically induced degradation of epigenetic targets","volume":"52","author":"Kabir","year":"2023","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.apsb.2026.03.021_bib51","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/s41573-022-00409-3","article-title":"The emerging role of mass spectrometry-based proteomics in drug discovery","volume":"21","author":"Meissner","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2026.03.021_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2023.08.008","article-title":"eIF3d controls the persistent integrated stress response","volume":"83","author":"Mukhopadhyay","year":"2023","journal-title":"Mol Cell"},{"key":"10.1016\/j.apsb.2026.03.021_bib53","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature18954","article-title":"eIF3d is an mRNA cap-binding protein that is required for specialized translation initiation","volume":"536","author":"Lee","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.03.021_bib54","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.molcel.2009.05.016","article-title":"RVB1\/RVB2: running rings around molecular biology","volume":"34","author":"Jha","year":"2009","journal-title":"Mol Cell"},{"key":"10.1016\/j.apsb.2026.03.021_bib55","article-title":"GART functions as a novel methyltransferase in the RUVBL1\/\u03b2-Catenin signaling pathway to promote tumor stemness in colorectal cancer","volume":"10","author":"Tang","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.apsb.2026.03.021_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24825","article-title":"EIF3D promotes resistance to 5-fluorouracil in colorectal cancer through upregulating RUVBL1","volume":"37","author":"Li","year":"2023","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.apsb.2026.03.021_bib57","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13045-022-01224-4","article-title":"RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential","volume":"15","author":"Qu","year":"2022","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.apsb.2026.03.021_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102993","article-title":"M6A demethylase ALKBH5 regulates FOXO1 mRNA stability and chemoresistance in triple-negative breast cancer","volume":"69","author":"Liu","year":"2024","journal-title":"Redox Biol"},{"key":"10.1016\/j.apsb.2026.03.021_bib59","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1158\/0008-5472.CAN-22-0800","article-title":"ALKBH5-mediated m6A demethylation of GLUT4 mRNA promotes glycolysis and resistance to HER2-targeted therapy in breast cancer","volume":"82","author":"Liu","year":"2022","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2026.03.021_bib60","doi-asserted-by":"crossref","first-page":"5554","DOI":"10.1158\/1078-0432.CCR-12-0859","article-title":"Pyruvate kinase M2: multiple faces for conferring benefits on cancer cells","volume":"18","author":"Tamada","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.apsb.2026.03.021_bib61","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.canlet.2020.11.018","article-title":"Pyruvate kinase M2 (PKM2) in cancer and cancer therapeutics","volume":"503","author":"Zhu","year":"2021","journal-title":"Cancer Lett"},{"key":"10.1016\/j.apsb.2026.03.021_bib62","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.cell.2014.08.003","article-title":"PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis","volume":"158","author":"Yang","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2026.03.021_bib63","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41573-021-00320-3","article-title":"Pharmacological targeting of endoplasmic reticulum stress in disease","volume":"21","author":"Marciniak","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2026.03.021_bib64","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41568-020-00312-2","article-title":"Endoplasmic reticulum stress signals in the tumour and its microenvironment","volume":"21","author":"Chen","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.apsb.2026.03.021_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110767","article-title":"An eIF3d-dependent switch regulates HCMV replication by remodeling the infected cell translation landscape to mimic chronic ER stress","volume":"39","author":"Thompson","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.apsb.2026.03.021_bib66","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nm.2293","article-title":"Regulation of glucose homeostasis through a XBP-1\u2013FoxO1 interaction","volume":"17","author":"Zhou","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2026.03.021_bib67","doi-asserted-by":"crossref","first-page":"6266","DOI":"10.1074\/jbc.M111.331264","article-title":"Cdc37\/Hsp90 protein-mediated regulation of IRE1\u03b1 protein activity in endoplasmic reticulum stress response and insulin synthesis in INS-1 cells","volume":"287","author":"Ota","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2026.03.021_bib68","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/nm.2059","article-title":"A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6-dependent B cell lymphomas","volume":"15","author":"Cerchietti","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2026.03.021_bib69","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ceb.2020.01.010","article-title":"Endoplasmic reticulum-plasma membrane contacts: principals of phosphoinositide and calcium signaling","volume":"63","author":"Stefan","year":"2020","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.apsb.2026.03.021_bib70","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41571-019-0322-1","article-title":"AKT inhibition improves OS in TNBC","volume":"17","author":"Killock","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.apsb.2026.03.021_bib71","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1158\/2159-8290.CD-18-1218","article-title":"PARP inhibitor efficacy depends on CD8+ T-cell recruitment via intratumoral STING pathway activation in BRCA-deficient models of triple-negative breast cancer","volume":"9","author":"Pantelidou","year":"2019","journal-title":"Cancer Discov"},{"key":"10.1016\/j.apsb.2026.03.021_bib72","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1158\/2159-8290.CD-11-0348","article-title":"PI3K inhibition impairs BRCA1\/2 expression and sensitizes BRCA-proficient triple-negative breast cancer to PARP inhibition","volume":"2","author":"Ibrahim","year":"2012","journal-title":"Cancer Discov"},{"key":"10.1016\/j.apsb.2026.03.021_bib73","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1158\/1078-0432.CCR-18-1891","article-title":"A phase II study of talazoparib after platinum or cytotoxic nonplatinum regimens in patients with advanced breast cancer and germline BRCA1\/2 mutations (ABRAZO)","volume":"25","author":"Turner","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.apsb.2026.03.021_bib74","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1200\/JCO.19.00368","article-title":"Capivasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer: the PAKT trial","volume":"38","author":"Schmid","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.apsb.2026.03.021_bib75","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1158\/1078-0432.CCR-21-2498","article-title":"Functional mapping of AKT signaling and biomarkers of response from the FAIRLANE trial of neoadjuvant ipatasertib plus paclitaxel for triple-negative breast cancer","volume":"28","author":"Shi","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.apsb.2026.03.021_bib76","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41571-020-00467-9","article-title":"Pembrolizumab can delay progression of TNBC","volume":"18","author":"Killock","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.apsb.2026.03.021_bib77","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1200\/JCO.2016.70.8297","article-title":"Efficacy and safety of anti-Trop-2 antibody drug conjugate sacituzumab govitecan (IMMU-132) in heavily pretreated patients with metastatic triple-negative breast cancer","volume":"35","author":"Bardia","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.apsb.2026.03.021_bib78","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1158\/1078-0432.CCR-16-2401","article-title":"Synthetic lethality exploitation by an Anti-Trop-2-SN-38 antibody\u2013drug conjugate, IMMU-132, plus PARP inhibitors in BRCA1\/2-wild-type triple-negative breast cancer","volume":"23","author":"Cardillo","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.apsb.2026.03.021_bib79","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1038\/s41598-019-40617-3","article-title":"A novel lactate dehydrogenase inhibitor, 1-(phenylseleno)-4-(trifluoromethyl) benzene, suppresses tumor growth through apoptotic cell death","volume":"9","author":"Kim","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2026.03.021_bib80","article-title":"Oleanolic acid suppresses aerobic glycolysis in cancer cells by switching pyruvate kinase type M isoforms","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2026.03.021_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103620","article-title":"Discovery of novel glyceraldehyde-3-phosphate dehydrogenase inhibitor via docking-based virtual screening","volume":"96","author":"Li","year":"2020","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.apsb.2026.03.021_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.106006","article-title":"Autophagy: a promising target for triple negative breast cancers","volume":"175","author":"Abd El-Aziz","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.apsb.2026.03.021_bib83","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1038\/s41467-020-17395-y","article-title":"Autophagy deficiency promotes triple-negative breast cancer resistance to T cell-mediated cytotoxicity by blocking tenascin-C degradation","volume":"11","author":"Li","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.03.021_bib84","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1002\/1878-0261.13180","article-title":"Autophagy inhibits cancer stemness in triple-negative breast cancer via miR-181a-mediated regulation of ATG5 and\/or ATG2B","volume":"16","author":"Park","year":"2022","journal-title":"Mol Oncol"},{"key":"10.1016\/j.apsb.2026.03.021_bib85","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1158\/1078-0432.CCR-13-2060","article-title":"Autophagy inhibition augments the anticancer effects of epirubicin treatment in anthracycline-sensitive and -resistant triple-negative breast cancer","volume":"20","author":"Chittaranjan","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.apsb.2026.03.021_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121458","article-title":"Nanoprodrug ratiometrically integrating autophagy inhibitor and genotoxic agent for treatment of triple-negative breast cancer","volume":"283","author":"Wang","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2026.03.021_bib87","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41568-021-00380-y","article-title":"The plasticity of mRNA translation during cancer progression and therapy resistance","volume":"21","author":"Fabbri","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.apsb.2026.03.021_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116882","article-title":"Design, synthesis and biological evaluation of plant-derived miliusol derivatives achieve TNBC profound regression in vivo","volume":"279","author":"Zhao","year":"2024","journal-title":"Eur J Med Chem"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383526001747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383526001747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T18:14:49Z","timestamp":1783016089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383526001747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":88,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2211383526001747"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2026.03.021","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"(+)-Miliusol suppresses the Warburg effect and induces regulated cell death in triple-negative breast cancer through targeting EIF3D and remodeling cancer metabolism","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2026.03.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}